Innovative cancer treatment may sometimes cause cancer, FDA says

By The New York Times
| November 29, 2023

CAR-T was first approved in 2017 for life-threatening blood cancers. The FDA says it had received 19 reports of new blood cancers in patients who received the treatment.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...